Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Cognition Therapeutics stock

Learn how to easily invest in Cognition Therapeutics stock.

Cognition Therapeutics is a biotechnology business based in the US. Cognition Therapeutics shares (CGTX) are listed on the NASDAQ and all prices are listed in US Dollars. Cognition Therapeutics employs 19 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy Cognition Therapeutics stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – CGTX. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award


  • Easy to use platform with low fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100

Promoted for easy user experience


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Cognition Therapeutics stock price (NASDAQ: CGTX)

Use our graph to track the performance of CGTX stocks over time.

Cognition Therapeutics shares at a glance

Information last updated 2023-01-28.
Latest market close$2.12
52-week range$1.07 - $4.79
50-day moving average $2.23
200-day moving average $2.19
Wall St. target price$10.25
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.80

Buy Cognition Therapeutics stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
Stocks, Options, ETFs, Cryptocurrency
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Cognition Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cognition Therapeutics price performance over time

Historical closes compared with the close of $2.12 from 2023-02-03

1 week (2023-01-27) 4.95%
1 month (2023-01-04) -7.02%
3 months (2022-11-04) 18.44%
6 months (2022-08-04) -41.11%
1 year (2022-02-04) -51.93%
2 years (2021-01-31) N/A
3 years (2020-01-31) N/A
5 years (2018-01-31) N/A

Cognition Therapeutics financials

Gross profit TTM $0
Return on assets TTM -86%
Return on equity TTM -126.08%
Profit margin 0%
Book value $1.64
Market capitalisation $58.6 million

TTM: trailing 12 months

Cognition Therapeutics share dividends

We're not expecting Cognition Therapeutics to pay a dividend over the next 12 months.

You may also wish to consider:

Cognition Therapeutics overview

Cognition Therapeutics, Inc. , a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical trial for the treatment of mild-to-moderate Alzheimer's disease, as well as has completed Phase I clinical trial to treat early-stage Alzheimer's disease; in Phase II clinical trial for the treatment of dementia with Lewy bodies (DLB); and in preclinical trial to treat dry age-related macular degeneration (AMD). The company is also developing CT2168 for the treatment of synucleinopathies, which include DLB and Parkinson's disease; and CT2074 to treat dry AMD. Cognition Therapeutics, Inc. was incorporated in 2007 and is headquartered in Purchase, New York. .

Frequently asked questions

What percentage of Cognition Therapeutics is owned by insiders or institutions?
Currently 8.905% of Cognition Therapeutics shares are held by insiders and 54.45% by institutions.
How many people work for Cognition Therapeutics?
Latest data suggests 19 work at Cognition Therapeutics.
When does the fiscal year end for Cognition Therapeutics?
Cognition Therapeutics's fiscal year ends in December.
Where is Cognition Therapeutics based?
Cognition Therapeutics's address is: 2500 Westchester Avenue, Purchase, NY, United States, 10577
What is Cognition Therapeutics's ISIN number?
Cognition Therapeutics's international securities identification number is: US19243B1026

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site